comparemela.com

Latest Breaking News On - Hans eriksson - Page 7 : comparemela.com

COMPASS Pathways: COMP360 psilocybin study of 89 healthy participants published in Journal of Psychopharmacology

Study demonstrates feasibility of simultaneous administration of COMP360 psilocybin in a controlled setting to healthy participants with 1:1 therapist support London, UK - 4 January 2022

Depression doesn t look alike for everyone – so why should the treatments for it?

Dr. Hans Eriksson, chief clinical development officer at HMNC Brain Health, discusses the ways AI-driven precision psychiatry can be leveraged to target the use of medications and improve patient outcomes.

Investegate |HMNC Holding GmbH Announcements | HMNC Holding GmbH: HMNC Brain Health to Participate in the H C Wainwright 2nd Annual Psychedelics Conference

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.